Found 29 matching trials
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)
PHASE3This is a randomized double-blind vehicle-controlled Phase 3 study to evalu...
Location
Dermavant Investigative Site
A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region
PHASE4This is an open-label, multi-center study to evaluate the efficacy and safe...
Location
Dermavant Investigative Site
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)
PHASE3This is a randomized, double-blind, vehicle-controlled Phase 3 study to eva...
Location
Dermavant Investigative Site
A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)
PHASE2This study will evaluate the efficacy and safety of two concentrations (0.5...
Location
GSK Investigational Site
Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)
PHASE2The purpose of this prospective study is to evaluate the degree of post-inf...
Status
Enrolling By Invitation
Location
Wake Forest University Health Sciences Department of Dermatology
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)
PHASE3This is a double-blind, randomized, vehicle controlled Phase 3 study to eva...
Location
Dermavant Investigative Site
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
PHASE3This is an open-label, multi-center, Phase 3 study to evaluate tapinarof cr...
Status
Active Not Recruiting
Location
Northwest Arkansas Clinical Trials Center, PLLC
Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)
PHASE3This is a long-term, open-label, multicenter, study to evaluate the safety ...
Location
Dermavant Investigative Site
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
PHASE4This study is being done to test a microdevice, which is a small device des...
Location
University of California, San Francisco
A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis
PHASE4This is an open-label, multi-center study to evaluate the efficacy and safe...
Location
Dermavant Investigative Site